Combining Endocannabinoid Boosters With Anti-Inflammatory Drugs Reduced Post-Surgical Pain in Mice | Research

The takeaway

Blocking the enzyme that breaks down endocannabinoids (MAGL) reduced post-surgical pain through CB2 receptors, and combining sub-effective doses with an NSAID produced additive pain relief.

Researchers and readers interested in non-opioid pain management strategies and the endocannabinoid system's role in surgical pain.

Sub-threshold doses combined to produce significant pain relief

What the researchers found

MAGL inhibitors (JZL184 and MJN110) reduced mechanical pain sensitivity after hindpaw surgery in mice. The pain relief worked through CB2 receptors, not CB1. Importantly, combining doses of JZL184 and diclofenac that were individually too low to reduce pain produced significant relief when given together. Repeated JZL184 administration did not lead to tolerance.

Why it matters

Post-surgical pain management often relies on opioids, which carry addiction risks. This study demonstrates that boosting the body's own endocannabinoids can reduce pain, and that combining this approach with common anti-inflammatory drugs could allow lower doses of each, potentially reducing side effects.

The numbers in context

JZL184 effective at 4+ mg/kg; MJN110 at 5+ mg/kg; diclofenac at 16.67+ mg/kg. Sub-threshold combination: JZL184 (1 mg/kg) + diclofenac (1.85 mg/kg) together produced significant pain relief. CB2 antagonist SR144528 (3 mg/kg) blocked JZL184's effects; CB1 antagonist rimonabant (3 mg/kg) did not.

How the study worked

Male and female C57BL/6J mice underwent hindpaw incision surgery. Mechanical allodynia was measured 24 hours post-surgery using von Frey filaments. Dose-response curves were established for MAGL inhibitors and diclofenac. CB1 and CB2 antagonists were used to identify receptor mechanisms. Repeated dosing tested for tolerance. Hindpaw cytokines were measured via multiplex ELISA.

What this study cannot tell us

Animal study; translation to humans uncertain. Hindpaw incision is a simplified model of surgical pain. MAGL inhibition did not reduce inflammatory cytokines despite behavioral pain relief, suggesting the mechanism may be primarily neural rather than anti-inflammatory. Both sexes used but sex-specific analysis not detailed.

How to read the evidence

Preliminary: well-designed animal study with mechanistic detail, but no human data yet.

When this study was published

Published in 2025.

The bigger picture

The finding that endocannabinoid-based pain relief works through CB2 (not CB1) receptors in this model is significant because CB2 activation avoids the psychoactive effects associated with CB1. The additive interaction with NSAIDs suggests a practical combination strategy that could reduce reliance on opioids after surgery.

Questions still open

Could MAGL inhibitors combined with NSAIDs replace opioids for post-surgical pain in humans?
Why did MAGL inhibition reduce pain behavior without affecting inflammatory markers?
Would this combination approach work for other types of surgical procedures?

Common questions

Can the endocannabinoid system help with pain after surgery?

In mice, boosting natural endocannabinoids by blocking the MAGL enzyme reduced post-surgical pain. The effect worked through CB2 receptors and did not develop tolerance with repeated use.

Could combining cannabinoid-based treatments with NSAIDs improve pain relief?

This mouse study found that individually ineffective doses of a MAGL inhibitor and the NSAID diclofenac produced meaningful pain relief when combined, suggesting an additive interaction.

Read the original research

Combined Endocannabinoid and Cyclooxygenase Inhibition Additively Attenuates Post-Surgical Pain.

Cannabis and cannabinoid research, 10(1), e102-e111

View on PubMed ↗Publisher’s paper ↗

Citation

Rodriguez, Carl E B; Vanegas, S Olivia; Reck, A Matthew; Schrom, Yasmin; Kinsey, Steven G. (2025). Combined Endocannabinoid and Cyclooxygenase Inhibition Additively Attenuates Post-Surgical Pain.. Cannabis and cannabinoid research, 10(1), e102-e111. https://doi.org/10.1089/can.2024.0088